ELISA Kit for Hexokinase 2 (HK2)

HK II; Muscle form hexokinase

Specificity

This assay has high sensitivity and excellent specificity for detection of Hexokinase 2 (HK2).
No significant cross-reactivity or interference between Hexokinase 2 (HK2) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Hexokinase 2 (HK2) and the recovery rates were calculated by comparing the measured value to the expected amount of Hexokinase 2 (HK2) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 81-98 94
EDTA plasma(n=5) 82-98 89
heparin plasma(n=5) 78-103 84

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Hexokinase 2 (HK2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Hexokinase 2 (HK2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Hexokinase 2 (HK2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 98-105% 92-101% 81-95% 95-105%
EDTA plasma(n=5) 91-99% 81-98% 83-93% 93-101%
heparin plasma(n=5) 89-96% 91-98% 80-102% 94-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Anti-Cancer Drugs 3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2. 10.1097/CAD.0000000000000502
Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPD352Hu01 Recombinant Hexokinase 2 (HK2) Positive Control; Immunogen; SDS-PAGE; WB.
RPD352Hu02 Recombinant Hexokinase 2 (HK2) Positive Control; Immunogen; SDS-PAGE; WB.
PAD352Hu01 Polyclonal Antibody to Hexokinase 2 (HK2) WB; IHC; ICC; IP.
PAD352Hu02 Polyclonal Antibody to Hexokinase 2 (HK2) WB; IHC; ICC; IP.
MAD352Hu21 Monoclonal Antibody to Hexokinase 2 (HK2) WB; IHC; ICC; IP.
SED352Hu ELISA Kit for Hexokinase 2 (HK2) Enzyme-linked immunosorbent assay for Antigen Detection.